Biologos, a manufacturer of custom sterile-filtered liquid solutions, has appointed Hetal Patel as Chief Executive Officer (CEO).
The appointment follows recent investments in facilities and capabilities, and the acquisition of Biologos by Ampersand in 2024.
Patel brings over 25 years of experience to the role and has been at Biologos since 2024, when she joined as Chief Operating Officer (COO). During this time, she helped to ensure operational readiness to support customers and to position the company for long-term growth.
Patel said: “Biologos has an exceptional legacy built on integrity, agility, and an unwavering commitment to customers.
“With Ampersand’s support and the investments we’ve made in our people, facilities, and capabilities, we are uniquely positioned to help customers accelerate development timelines, ensure supply continuity, and confidently scale from early research through GMP manufacturing.”
Eric Lev, General Partner, Ampersand Capital Partners, said: “For five decades, Biologos has earned the trust of its customers through consistent performance and exceptional service.
“With Hetal’s leadership and the company’s expanded capabilities, Biologos is well positioned to deepen existing customer relationships and continue expanding into high-growth biopharma and CGT markets.”